Login / Signup

Epidemiological study of gastrointestinal helminths among dogs from Northeastern Nigeria: a potential public health concern.

Saleh Mohammed JajereJallailudeen Rabana LawalAminu ShittuIbrahim WaziriDauda Mohammed GoniFolorunso Oludayo Fasina
Published in: Parasitology research (2022)
Understanding the epidemiology of canine parasitic infections, gastrointestinal helminthic infections in particular, is crucial for designing an efficient control programs targeted at minimizing the risks of zoonotic transmission. A total of 470 dogs attending veterinary clinics in Northeastern Nigeria were screened for gastrointestinal helminths using standard parasitological techniques. Epidemiological risk factors associated with the canine parasitic infections were assessed using multivariable logistic regression analysis. In total, 77.9% (366/470) of dogs had harboured one or more species of the gastrointestinal helminths: Ancylostoma caninum (40.2%), Toxocara canis (35.1%) Trichuris vulpis (26.6%), Spirocerca lupi (5.7%), Taenia/Echinococcus (12.3%), Dipylidium caninum (10.9%) and Diphyllobothriid ova (2.8%). Female dogs (OR=2.1; p=0.02), local breeds (OR=2.3; p<0.01), younger dogs (OR=3.2; p<0.001), dogs adopted as security guards (OR=1.8; p<0.01) and poor body condition score (OR=3.1; p<0.001) were strongly associated with A. caninum infection. For T. canis and T. vulpis, younger dogs (OR=2.5; p=0.02 and OR=2.3; p<0.01) and poor body condition score (OR=4.2; p<0.001 and OR=2.2; p<0.01) were the strong predictors for infection, whereas female dogs (OR=2.8; p=0.02), younger dogs (OR=4.1; p<0.001) and poor body condition score (OR=4.0; p<0.001) were strongly associated with D. caninum infection in dogs. The results revealed high prevalence of gastrointestinal helminths-some of which have zoonotic potential-among dogs underlying huge public health risk.
Keyphrases
  • public health
  • health risk
  • emergency department
  • mental health
  • risk factors
  • toxoplasma gondii
  • drinking water
  • human health
  • cancer therapy
  • tertiary care